137 employees
Asuragen is a fully integrated diagnostics company developing mRNA-based solutions for molecular oncology and early detection of cancer.
2006
$49M
from 3 investors over 3 rounds
Asuragen raised $19M on December 10, 2007
Investors: Telegraph Hill Partners and PTV Healthcare Capital
Asuragen raised $49M on June 1, 2006
Investors: Telegraph Hill Partners